Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Galena Biopharma, Inc. (GALE) 2.51 -0.04
Price Open:2.61Day's Range:0.00000 - 3.00000
Price Close:2.6052wk Range:0.00000 - 3.54
Price Day Change:-0.04Volume:765,099
Price % Change:-1.54Market Cap:212.5M
Bid:2.51000PE Ratio:0
Ask:2.52000EPS Diluted:-0.274
Trade GALE NOW!

The Latest On GALE

Benzinga's Top Initiations 5/22/13 8:46am
Galena Biopharma Acquires Abstral Sublingual Tablets in US 3/18/13 6:13am
Benzinga's Top Initiations 12/31/12 10:47am
UPDATE: Piper Jaffray Initiates Galena Biopharma at Overweight on ImmunoRx Potential 12/31/12 9:17am
Mid-Day Market Update: Markets Rising, Gun Stocks Feel the Heat 12/18/12 2:36pm
Mid-Morning Market Update: Markets Rise, Firearm Stocks Take a Beating 12/18/12 12:07pm
Morning Market Losers 12/18/12 11:11am
Galena Biopharma Announces Results From NeuVax Phase 1/2 Trials 12/7/12 8:18am
Galena Biopharma, Leica Biosystems Partner on Development of Companion Diagnostic for HER2 Beast Cancer Screening 12/6/12 8:13am
Morning Market Movers 12/4/12 10:47am
Galena Biopharma Announces Partnership with Teva 12/4/12 8:13am
Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel 12/4/12 8:10am
more
Press Releases
Galena Biopharma to Present at the 2013 Marcum MicroCap Conference 5/23/13 GlobeNewswire
VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial Results 5/9/13 GlobeNewswire
Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting 5/9/13 GlobeNewswire
William L. Ashton Joins Galena Biopharma's Board of Directors 5/1/13 GlobeNewswire
Galena Biopharma to Present at the 12th Annual Needham Healthcare Conference 4/24/13 GlobeNewswire
Galena Biopharma to Present at the 2013 BIO International Convention 4/16/13 GlobeNewswire
Galena Biopharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference 3/29/13 GlobeNewswire
Galena Biopharma Acquires Abstral(R) (fentanyl) Sublingual Tablets in U.S., a Novel, Best-in-Class Treatment Approved for Breakthrough Cancer Pain 3/18/13 GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Gains 32% YTD and Adds Second Generation Firms for 2013 3/15/13 Business Wire
Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM) 3/14/13 GlobeNewswire
Galena Biopharma Reports Year-End 2012 Financial Results 3/12/13 GlobeNewswire
Frost & Sullivan Applauds Galena Biopharma for its Breakthrough Breast Cancer Vaccine, NeuVax™ 3/12/13 Newswire

Get the latest GALE stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Galena Biopharma, Inc. stock price.

Partner Headlines
Galena Biopharma (GALE): Timing is Still Everything 5/1/13
Galena Biopharma: Clinical Programs Remain on Track and Valuation is Attractive - Analyst Blog 2/11/13
SPA for Aeterna Zentaris Candidate - Analyst Blog 1/2/13
Galena On Track to Advance NeuVax - Analyst Blog 12/10/12
Get Thursday's Trading Started on the Right Foot: GALE, TSL, and GPOR Get Dissected. 11/29/12
Different Reason, Same Result: CNDO, ZAZA, and GALE Drop Key Hints. 11/13/12
WellPoint, Iron Mountain Incorporated Among Stocks Up on High Volume Wednesday 8/29/12
MOMENTUM TRADERS ALERT: Winnebago Continues Soaring (WGO, GALE, BONE) 7/19/12
Skin scarring research 7/17/12
For Galena Biopharma (GALE) Shareholders, It Could be a Long Five Months 7/16/12
MOMENTUM TRADERS ALERT: Galena Biopharma Soaring (GALE, PFE, BMY) 6/26/12
Regrouping the Breast Cancer Race's Contenders: IMGN, CLDX, GENE, GNBT, RHHBY, GALE 6/21/12